Sex Enhancement Raw Powder Series Yohimbine Hydrochloride / Yohimbine HCL
Abstrait
Yohimbine has been shown in human studies to be effective in the treatment of male impotence. Yohimbine has been shown to be effective in the treatment of orgasmic dysfunction in men. Yohimbine has also been used to treat hypoactive sexual desire disorder (reduced libido) in women. Increase muscular tension or urinary function no damage sex; Accelerate human body energy metabolism, increase energy supply.
Yohimbine has been used to facilitate recall of traumatic memories in the treatment of post traumatic stress disorder (PTSD). Use of yohimbine outside therapeutic settings may not be appropriate for persons suffering from PTSD. In pharmacology, yohimbine is used as a probe for α 2-adrenoceptor. In veterinary medicine, yohimbine is used to reverse anesthesia from the drug xylazine in small and large animals.
Yohimbine hydrochloride (HPLC)
| General information |
| Part used |
Bark |
Solvents used |
L'eau & éthanol |
| Boranical source |
Pausinystalia yohimbe |
Country of origin |
Chine |
| ÉLÉMENTS |
SPECIFICATION |
METHODS |
RÉSULTATS |
| Physical&Chemical data |
| Couleur |
Blanc |
Organoleptic |
Se conformer |
| Odour |
Characteristic |
|
Se conformer |
| Apparence |
Fine powder |
|
Se conformer |
| Analytical quality |
| Identification |
Identical to R.S. sample |
HPTLC |
Identical |
| Yohimbine hydrochloride |
≥98,0 % |
HPLC(on anhydrous basis) |
99.16% |
| Sieve analysis |
100% through 80 engrener |
USP34<786> |
Se conformer |
| L'eau (KF) |
≤1.0% |
Eur.Ph.7.0[2.5.12] |
0.06% |
| Total ash |
≤1.0% |
Eur.Ph.7.0[2.4.16] |
0.03% |
| Contaminants |
| Mener (Pb) |
≤3.0mg/kg |
Eur.Ph.7.0<2.2.58>ICP-MS |
0.1534mg/kg |
| Arsenic (As) |
≤2.0mg/kg |
Eur.Ph.7.0<2.2.58>ICP-MS |
0.0105mg/kg |
| Cadmium (Cd) |
≤1.0mg/kg |
Eur.Ph.7.0<2.2.58>ICP-MS |
<0.01mg/kg |
| Mercure (Hg) |
≤0.1mg/kg |
Eur.Ph.7.0<2.2.58>ICP-MS |
<0.01mg/kg |
| Solvents residue |
Meet Eur.Ph.7.0<5.4> |
Eur.Ph.7.0<2.4.24> |
Se conformer |
| Pesticides residue |
Meet USP Requirements |
USP34<561> |
Se conformer |
| Microbiological |
| Tltal plate count |
≤10000 cfu/g |
USP34<61> |
10 cfu/g |
| Yeast & mold |
≤1000 cfu/g |
USP34<61> |
10 cfu/g |
| E.Coli. |
Négatif |
USP34<62> |
Se conformer |
| Salmonella |
Négatif |
USP34<62> |
Se conformer |
| General status |
| Non-irradiation |
≤700 |
EN13751:2002<PSL> |
310 |
Application
Increase muscular tension or urinary function no damage sex; Accelerate human body energy metabolism, increase energy supply.
Yohimbine has been shown in human studies to be effective in the treatment of male impotence. Yohimbine has been shown to be effective in the treatment of orgasmic dysfunction in men. Yohimbine has also been used to treat hypoactive sexual desire disorder (reduced libido) in women.
Yohimbine has been used to facilitate recall of traumatic memories in the treatment of post traumatic stress disorder (PTSD). Use of yohimbine outside therapeutic settings may not be appropriate for persons suffering from PTSD. In pharmacology, yohimbine is used as a probe for α 2-adrenoceptor. In veterinary medicine, yohimbine is used to reverse anesthesia from the drug xylazine in small and large animals
Directeur commercial